Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 3/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.40 |
| ▸ | LDHA | P00338 | 1/20 | 0.40 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.40 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.40 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | KDM5C | P41229 | 2/20 | 0.33 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.33 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.33 |
| ▸ | KDM6B | O15054 | 1/20 | 0.33 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.33 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31613206 | 0.96 | CYP2D6 (0.43) | CYP2D6CYP2C19LMNAEGLN1LDHA | |
| Ethylene SCHEMBL8519352 | 0.93 | CYP2D6 (0.41) | CYP2D6CYP2C19LMNAEGLN1LDHA | |
| SCHEMBL2240590 | 0.89 | CA3 (0.42) | CYP2D6CYP2C19LMNAEGLN1LDHA | |
| SCHEMBL18886295 | 0.89 | PRMT1 (0.46) | CYP2D6CYP2C19LMNAEGLN1LDHA | |
| SCHEMBL3174690 | 0.85 | KDM4E (0.50) | CYP2D6CYP2C19POLBKDM4EPRMT1 | |
| SCHEMBL8958360 | 0.85 | KDM4E (0.43) | CYP2D6CYP2C19POLBKDM4EPRMT1 | |
| SCHEMBL1863794 | 0.84 | — | — | |
| SCHEMBL6421935 | 0.84 | — | — | |
| SCHEMBL3557960 | 0.84 | KDM4E (0.57) | CYP2D6CYP2C19TSHRUSP2KDM4E | |
| SCHEMBL15871737 | 0.82 | KDM4E (0.55) | POLBKDM4EPRMT1MAPK1HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2841496-B1 | RUBBER COMPOSITIONS | ALLNEX GERMANY GMBH (DE) | 2022-10-26 | — | — | EP | claimed |
| CN-113563493-A | Hydrophobic polysaccharide and preparation method and application thereof | 蚌埠医学院 | 2021-10-29 | — | — | CN | claimed |
| CN-104245814-B | Rubber composition | 湛新德国有限公司 | 2016-11-09 | — | — | CN | claimed |
| CN-104245814-A | Rubber compositions | CYTEC SURFACE SPECIALTIES GERMANY GMBH | 2014-12-24 | — | — | CN | claimed |
| EP-2710160-A2 | RECOVERY REACTOR | UPL Limited (IN) | 2014-03-26 | — | — | EP | claimed |
| WO-2012160494-A2 | RECOVERY REACTOR | UNITED PHOSPHORUS LIMITED (IN) | 2012-11-29 | — | — | WO | claimed |
| US-4971598-A | Reaction products of alkenyl succinimides with ethylenediamine carboxy acids as fuel detergents | MOBIL OIL CORPORATION (US) | 1990-11-20 | — | — | US | claimed |
| EP-0011049-B1 | AMINOPLAST RESIN, ITS PREPARATION AND ITS USE | CIBA-GEIGY AG (CH) | 1982-08-04 | — | — | EP | claimed |
| EP-0011049-A1 | Aminoplast resin, its preparation and its use | CIBA-GEIGY AG (CH) | 1980-05-14 | — | — | EP | claimed |
| JP-52117423-A | — | — | None | — | — | JP | disclosed |
| CN-119947760-A | Antibody drug complexes comprising Toll-like receptor 7/8 dual agonist compounds | 安斯泰来制药株式会社 | 2025-05-06 | — | — | CN | disclosed |
| CN-113453724-B | Sulfonylmaleimide-based linkers and corresponding conjugates | 皮埃尔法布雷医药公司 | 2025-02-25 | — | — | CN | disclosed |
| US-20240398963-A1 | DRUG DELIVERY SYSTEM FOR LOCALLY DELIVERING THERAPEUTIC AGENTS AND USES THEREOF | COVAL BIOPHARMA (SHANGHAI) CO., LTD. (CN) | 2024-12-05 | — | — | US | disclosed |
| CN-118215676-A | Specific conjugation of antibody drug conjugates | 杭州多禧生物科技有限公司 | 2024-06-18 | — | — | CN | disclosed |
| US-4897255-A | Metal radionuclide labeled proteins for diagnosis and therapy | NEORX CORPORATION (US) | 1990-01-30 | — | — | US | disclosed |
| EP-0284071-A2 | Metal-radionuclide-labeled proteins and glycoproteins for diagnosis and therapy | NEORX CORPORATION (US) | 1988-09-28 | — | — | EP | disclosed |
| EP-0188256-A2 | Metal radionuclide labeled proteins for diagnosis and therapy | NeoRx (US) | 1986-07-23 | — | — | EP | disclosed |
| EP-0011049-B1 | AMINOPLAST RESIN, ITS PREPARATION AND ITS USE | CIBA-GEIGY AG (CH) | 1982-08-04 | — | — | EP | disclosed |
| EP-0011049-A1 | Aminoplast resin, its preparation and its use | CIBA-GEIGY AG (CH) | 1980-05-14 | — | — | EP | disclosed |
| JP-S52117423-A | AGRICULTURAL AND HORTICULTURAL MICROBICIDAL COMPOSITION | KUMIAI CHEM IND CO LTD | 1977-10-01 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240398963-A1 | DRUG DELIVERY SYSTEM FOR LOCALLY DELIVERING THERAPEUTIC AGENTS AND USES THEREOF | TIE1, KDR, TEK | CYP2D6 4318/4885CYP2C19 4838/4885LMNA 2799/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.